First Time Loading...

Reata Pharmaceuticals Inc
NASDAQ:RETA

Watchlist Manager
Reata Pharmaceuticals Inc Logo
Reata Pharmaceuticals Inc
NASDAQ:RETA
Watchlist
Price: 172.36 USD
Updated: Jun 3, 2024

Reata Pharmaceuticals Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Reata Pharmaceuticals Inc
Net Issuance of Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Reata Pharmaceuticals Inc
NASDAQ:RETA
Net Issuance of Debt
$72.6m
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Issuance of Debt
-$11.2B
CAGR 3-Years
N/A
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Net Issuance of Debt
$17.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Issuance of Debt
$33.8B
CAGR 3-Years
N/A
CAGR 5-Years
50%
CAGR 10-Years
67%
Merck & Co Inc
NYSE:MRK
Net Issuance of Debt
$3.4B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Net Issuance of Debt
$7.4B
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is Reata Pharmaceuticals Inc's Net Issuance of Debt?
Net Issuance of Debt
72.6m USD

Based on the financial report for Jun 30, 2023, Reata Pharmaceuticals Inc's Net Issuance of Debt amounts to 72.6m USD.

What is Reata Pharmaceuticals Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
4%